Shorr AF, Jones ME, Friedmann S, Ionescu D, et al. Ceftobiprole versus ceftriaxone +/- linezolid in Community-Acquired Bacterial Pneumonia (CABP): Re-analysis of a randomized, phase 3 study using 2020 FDA guidance. PLoS One 2025;20:e0326758.
PMID: 40554538